What are the top holdings of quant Business Cycle Fund?

quant Business Cycle Fund holds 12 equity positions; the largest is Piramal Finance Ltd at 10.87% of the portfolio, as on Aug 2026. Information only, not investment advice.

How concentrated is quant Business Cycle Fund?

Its single largest equity position is Piramal Finance Ltd, at 10.87% of the fund's disclosed portfolio.

As of when is this quant Business Cycle Fund portfolio?

Portfolio as on Aug 2026, taken from Quant Mutual Fund's public monthly portfolio disclosure.

What is the NAV of quant Business Cycle Fund?

The latest NAV (Net Asset Value) of quant Business Cycle Fund is ₹17.27 per unit, as on Aug 2026, sourced from AMFI's public scheme data. NAV changes daily with market movements. Information only, not investment advice.

What is the AUM of quant Business Cycle Fund?

quant Business Cycle Fund has a Monthly Average AUM (Assets Under Management) of ₹976.34 Cr, as per AMFI's latest published data. AUM reflects the total market value of all assets managed across all plans of this scheme. Information only, not investment advice.

Who manages quant Business Cycle Fund?

quant Business Cycle Fund is managed by Jignesh Shah; Sanjeev Sharma; Ankit A. Pande; Sandeep Tandon; Varun Pattani; Sameer Kate; Ayusha Kumbhat; Yug Tibrewal, as per AMFI's public disclosure. Fund manager details sourced from Kuvera/AMFI data. Information only, not investment advice.

What is the expense ratio of quant Business Cycle Fund?

quant Business Cycle Fund has a Total Expense Ratio (TER) of 1.39% p.a., as disclosed to AMFI. The TER is the annual cost of running the fund, deducted daily from the NAV. A lower TER means more of the fund's return flows to investors. Information only, not investment advice.

What is the 1-year NAV return of quant Business Cycle Fund?

quant Business Cycle Fund's NAV moved from ₹16.04 (Oct 2025) to ₹17.07 (Sep 2026), a change of 6.4% over approximately one year. NAV data sourced from AMFI. Past performance is not indicative of future returns. Information only, not investment advice.

What is the Sharpe ratio of quant Business Cycle Fund?

Based on roughly 12 months of NAV history, quant Business Cycle Fund has an annualized return of about 6.8% with 14.3% annualized volatility, giving a Sharpe ratio of 0.02 (assuming a 6.5% risk-free rate). A higher Sharpe ratio means more return per unit of risk taken. Past performance is not indicative of future returns.

:root{--background:#08090c;--background-2:#0c0e12;--foreground:#e9eaec;--card:#0e1014;--card-foreground:#e9eaec;--muted:#15171d;--muted-foreground:#9298a4;--border:#1e2129;--border-strong:#2b2f3a;--primary:#10b981;--primary-foreground:#052e22;--ring:#34d399;--positive:#34d399;--negative:#fb7185;--brand-600:#34d399}

WhoHolds

Smart-Beta / FactorVery High RiskQuant Mutual Fund

quant Business Cycle Fund

Portfolio as on Aug 2026 · 12 equity positions

Equity positions

Equity value

₹677 Cr

Top holding

10.87%

Piramal Finance Ltd

NAV per unit

₹17.27

Aug 2026

Avg AUM

₹976.34 Cr

Expense ratio

1.39% p.a.

Fund managers

Jignesh Shah, Sanjeev Sharma, Ankit A. Pande, Sandeep Tandon, Varun Pattani, Sameer Kate, Ayusha Kumbhat, Yug Tibrewal

Own another fund too? See how much they overlap →

Portfolio Structure & Asset Allocation Analysis

quant Business Cycle Fund is a Smart-Beta / Factor scheme managed by Quant MF Mutual Fund. As of disclosures dated Aug 2026, the scheme holds 12 equity positions with an estimated equity AUM of ₹976.34 Cr. The portfolio is anchored by its top conviction bet on Piramal Finance, which commands a weight of 10.87%of the fund's total assets.

From a sector allocation perspective, the fund managers have concentrated their largest bet on Pharmaceuticals & Biotechnology, representing 17.50% of the equity portfolio. This is followed by Finance (15.81%) and Telecom - Services (12.44%). Under SEBI's guidelines and based on its underlying assets, this scheme carries a Very High Risk risk classification.

Diversification Warning: High sector concentration can increase volatility. If you hold index heavyweights like Piramal Finance directly in your stock portfolio, adding this fund will compound your exposure to them. Ensure your holdings are balanced and check overlap with your existing schemes using our Mutual Fund Overlap Tool.

NAV history

₹17.07 per unit +6.4% vs Oct '25

Last 365 days · daily NAV from AMFI · quant Business Cycle Fund

Performance & risk

Annualized return

+6.8%

Volatility

14.3%

Sharpe ratio

0.02

Beta

0.81

explains 50% of moves

Alpha

+9.1%

vs. benchmark, annualized

Based on ~12 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio and alpha assume a 6.5% risk-free rate. Beta measures how much the fund moves with its benchmark (1.0 = in step); alpha is the return above what that beta would predict. Measured against the NAV of Kotak Nifty 50 Index Fund, standing in for the NIFTY 50 itself. A tracker's NAV is the index minus its running costs, so this compares funds against an investable benchmark rather than a costless one. Past performance does not guarantee future returns — not investment advice.

Sector allocation

12stocks

Pharmaceuticals & Biotechnology18%
Finance16%
Telecom - Services12%
Power12%
Auto Components7%
Electrical Equipment7%
Metals & Minerals Trading7%
Other22%

Top holdings

Top 10 holdings make up 63.6% of the portfolio · top 5 = 42.4%.

12 stocks

#
1	Piramal FinanceFinance₹107.08 Cr	10.87%	₹107.08 Cr	4.65 L
2	Aurobindo PharmaPharmaceuticals & Biotechnology₹99.14 Cr	10.07%	₹99.14 Cr	5.77 L
3	Indus TowersTelecom - Services₹84.27 Cr	8.56%	₹84.27 Cr	21.67 L
4	Adani Green EnergyPower₹80.20 Cr	8.14%	₹80.20 Cr	6.60 L
5	Samvardhana Motherson InternationalAuto Components₹47.15 Cr	4.79%	₹47.15 Cr	27.63 L
6	Premier EnergiesElectrical Equipment₹46.88 Cr	4.76%	₹46.88 Cr	4.52 L
7	Adani EnterprisesMetals & Minerals Trading₹46.75 Cr	4.75%	₹46.75 Cr	1.64 L
8	Lloyds Metals And EnergyMinerals & Mining₹41.23 Cr	4.19%	₹41.23 Cr	2.30 L
9	Tata ChemicalsChemicals & Petrochemicals₹38.03 Cr	3.86%	₹38.03 Cr	5.92 L
10	Zydus WellnessFood Products₹35.61 Cr	3.62%	₹35.61 Cr	6.71 L
11	LG Electronics IndiaConsumer Durables₹31.56 Cr	3.20%	₹31.56 Cr	1.86 L
12	BROOKS LaboratoriesPharmaceuticals & Biotechnology₹19.40 Cr	1.97%	₹19.40 Cr	29.16 L